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SUMMARY - Depression following a stroke, also referred to as post-stroke depression (PSD),
has long been recognized as one of the most common complications of stroke. PSD has significant
adverse consequences on the recovery of motor and cognitive deficits, as well as on the risk of mor-
tality associated with stroke. The prevalence of PSD varies over time with an apparent peak 3-6
months after stroke and subsequent decline reaching about 50% of the initial rates at one year. The
natural course of major depression after stroke has spontaneous remission typically 1 to 2 years after
stroke. However, it has also been observed that depression becomes chronic and may persist for more
than 3 years following stroke. On the other hand, minor depression appears to be more variable,
with both short term and long term depression occurring in these patients. Early recognition ofPSD
symptoms and introduction of pharmacological treatment is of great importance in the reduction of
stroke complications and stroke mortality as well as for better functional outcome.
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Introduction
In the acute stage of stroke, there is an important
change in sensorimotor interactions with both inter-
nal and external world; it is so called 'modified mental
processing'. Up to one third of stroke patients have
'modified mental processing'. Such patients have no,
or only poor, memory ofwhat actually happened dur-
ing the acute stage of stroke; it usually occurs without
specific damage to the classic anatomical structures
involved in memory processing". Another phenom-
enon, called anosognosia or poor recognition of the
neurologic deficit, can be present in the acute stage of
stroke. Therefore, post-stroke depression (PSD) needs
to be distinguished from emotional lability (sometimes
referred to as post-stroke emotionalism or catastroph-
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ic reactions). Post-stroke emotionalism is reported in
about 10% of stroke patients; it is an abnormal lability
of mood during which the patient laughs or cries for
no evident reason, suffers anxiety, apathy and loss of
psychic self-activation (athymhormia). Typically, the
patient does not feel the expected emotion associated
with this outward rcactiorr':".
Epidemiology
Prevalence rates of PSD range from 30% to 50%;
in four community-based studies 31.8% (range 30%-
44%), in studies carried out in acute hospitals 25%-
47%, and in studies conducted in rehabilitation cen-
ters 35%-47%5
The occurrence of PSD peaks three to six months
after stroke. In a study on 100 patients followed for
18 months, the symptoms ofPSD occurred in 46% of
patients in the first two months, whereas only 12% of
patients experienced their first symptoms 12 months
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after their stroke. Major depression and minor depres-
sion are the most frequently recognized manifestations
of PSD. The course of PSD can be rather lengthy, for
example, symptoms of major depression identified in
27% of stroke patients persisted for approximately one
year, whereas symptoms of minor depression lasted
for more than two years in 20% of stroke patients.
Clinical Manifestations
The clinical manifestations of PSD are similar to
those of idiosyncratic late onset depression, referred to
as vascular depression identified in patients that may
have overt or silent stroke(s) after age 65 or subcortical
bilateral white matter ischemic disease. The symptoms
of vascular depression consist of mood abnormalities,
neuropsychological disturbances with impairment of
executive functions, greater tendency to psychomo-
tor retardation, poor insight and impaired activities
of daily living. Vegetative symptoms consisting of
disturbances of sleep, libido and level of energy were
significantly more common in depressed than in non-
depressed stroke patients at initial evaluation, and at 3,
6, 12 and 24 months. The prevalence of major depres-
sion in four community-based studies ranged from
11% to 15%, in studies carried out in acute hospitals
from 10% to 27%, and in studies conducted in reha-
bilitation centers froml0% to 40%. The prevalence of
minor depression in four community-based studies
was 8%-12%, in studies carried out in acute hospitals
11%-20%, and in studies conducted in rehabilitation
centers 21%_44%6-10
The most frequently used scale for evaluating de-
pression in stroke patients is the Hamilton Depression
Rating Scale (HDRS); in the literature, the General
Health Qpestionnaire (GHQ), Hospital Anxiety and
Depression Scale (HAD), Aphasic Depression Rating
Scale (ADRS), or some modified scales such as the
Lausanne Emotion in Acute Stroke Study (LEASS)
can also be found in the literature. In the evaluation of
neurologic deficit and functional state, the National In-
stitute of Health Stroke Scale (NIHSS), Rankin Scale
and Barthel Index are most frequently used, whereas
the Mini Mental State Exam (MMSE) and Montreal
Cognitive Assessment (MoCA) are most widely em-
ployed for evaluation of cognitive functions".
There is a bidirectional relationship between stroke
and depression; there is a high prevalence of depres-
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sion in stroke patients and a higher risk of stroke in
depressed people (3.36 relative risk), even when other
conventional stroke risk factors (hypertension, dia-
betes, hyperlipidemia, heart disease and tobacco use)
are under control (2.67 relative risk) !". Eriksson et al.
demonstrated a previous stroke to be a risk factor for
PSD (OR 1.25; 95% CI, 1.12-1.38), whereas the Lau-
sanne Emotion in Stroke Study found no statistical
significance (3/2 studies)!' . Starkstein et al. showed
the patients with major PSD to have significantly
more cognitive deficits than non-depressed patients
having experienced a similar location and size of the
left hemisphere stroke; however, this did not apply to
strokes in the right hemisphere'<!".
The various risk factors associated with PSD in-
clude stroke location and size, temporal relation be-
tween PSD and stroke, and the size of the ventricles.
Clinical studies showed patients with stroke in the
middle cerebral artery territory to have longer duration
of PSD symptoms (82% had symptoms at 6-month
follow up, and 62% at 12- and 24-month follow up),
in comparison to patients with posterior circulation
strokes (20% at 6-month follow up, and 0% at 12- and
24-month follow up). Robinson et al. report that there
is so called anterior to posterior gradient, which is dif-
ferent according to the hemisphere involved, being
posterior to anterior for the left hemisphere and an-
terior to posterior for the right hemisphere. Bogous-
slavsky et al. showed PSD to be in strong correlation
with lesions in the subcortical white matter, thalamus,
basal ganglia and brain steam, rather than cortical le-
sions with specific cortical disturbance. Starkstein et
al. compared the magnitude of subcortical atrophy in
brain CT studies obtained immediately after stroke.
Patients that developed PSD had a significantly great-
er degree of atrophy at this stage than those that did
not14-19.
There is a higher frequency of left than right
strokes in PSD patients if the symptoms develop in
the first 10 days; the relationship disappears if the on-
set of symptoms takes place 3 months after stroke. If
the symptoms appear 1 year or later after stroke, right
sided lesions are more frequent. Overt sadness is more
frequently associated with left than with right lesions
(86% vs. 61%; P<0.05). Crying is also more frequent
in left than in right lesions (50% vs. 20%; P=0.02).
With right-side lesions, anosognosia is clearly asso-
ciated with neglect (95% vs. 34% for neglect vs. no
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neglect; P=O.Ol). Regional cerebral blood flow values
can also be useful in PSD prediction. Temporal lobe
hypo perfusion (lower cerebral blood flow (CBF) val-
ues in mesial temporal cortex) may reflect dysfunction
of the limbic system and be critical for the occurrence
of depressive symptoms in patients with subcortical
stroke. Patients with lower CBF in the left frontal or
right parieto-occipital regions were more depressed in
comparison with those with other brain lesions -v" .
When symptoms of depression appear more than
one year after stroke, right side lesions are more fre-
quent. Stroke severity and disability may cause a reac-
tive depressive process in the early stages after stroke,
but probably do not mediate the development of PSD
in the long term. There is a significantly higher preva-
lence ofPSD among patients with non-fluent aphasia,
but not in patients with fluent aphasia. The presence
ofPSD has been found to have unfavorable impact on
the recovery of cognitive function, recovery of ability
to perform activities of daily living and on the risk of
mortality". Large prospective studies have reported
poorer functional outcome at 15 months in patients
with depression 3 months after stroke and a strong
correlation of functional outcome and depressive
symptoms at both 3 months and 1 year after stroke.
Depression after stroke led to 3.4-fold increase in
mortality up to 10 years after stroke. Mood symptoms
on a self reported rating scale were associated with
12- and 24-month mortality after stroke (OR 2.4;
95% CI, 1.3-4.5 and OR 2.4; 95% CI, 1.4-4.1, re-
spectively). DESTRO study showed that depressive
symptoms were more severe in patients with earlier
onset, with no appreciable difference between those
diagnosed between the first and sixth month; they
were less severe in cases with later development of
depression (P<0.05). In multivariate analysis, male
patients had a 3 times higher probability than female
patients of good autonomy in both stair climbing and
activities of daily living (OR=3.32; 95% CI, 1.67-6.18
and OR=2.92; 95% CI, 1.63-5.42, respectively). Fe-
male patients had a higher risk ofwalking with a cane
(OR=1.69; 95%, CI 1.04-2.76) or of partial autonomy
with respect to activities of daily living (OR=1.90;
95%, CI 1.25-2.91). Difference in functional out-
come might be due to different approaches to their
disabilities, with women showing greater insecurity.
DESTRO study found a higher frequency of women
(35.39% without and 48.56% with PSD; P<O.OOl)22-
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2'. FINNSTROKE study showed an older age to
be an independent predictor of PSD. Eriksson et al.
found younger age to be a predictor of PSD13 DE-
STRO study found no statistical significance; these
results are still controversial. Meta-analysis showed
no statistical significance between the age and PSD
(13 of 17 studies in Hackett and Anderson). Twenty
percent of stroke patients will make no recovery, and
60% will make complete recovery. On evaluating re-
current stroke there must be information on previous
disability: activities of daily living dependent (11.6%
vs. 7%; OR 2.69; 95% CI, 2.44-0 2.97), living alone
(54.8% vs. 45.3%; OR 2.42; 95%, CI 2.18-2.69)29-31
Therapy and Prevention ofPost-Stroke
Depression
The aim of PSD treatment is to achieve complete
symptom remission of the depressive episode, which
may have favorable impact on recovery of neurologic
deficitsv". The efficacy of pharmacotherapy of PSD
has been investigated in several studies with tricy-
clic antidepressants (TCAs) and selective serotonin
reuptake inhibitors (SSRIs). Kimura et al. showed
that responders to treatment with antidepressant
medication had higher MMSE scores compared with
placebo-". Gianotti et al. compared recovery of mo-
tor deficit and disability in PSD patients treated with
antidepressant medications versus placebo (treated
patients were significantly more likely to achieve
symptom remission}". Prevention with sertraline
(50-150 mg/day) was investigated during one year in
a double blind study; 8.3% of treated patients devel-
oped PSD as compared with 22.8% of patients on pla-
cebo (P=0.037?S Robinson et al. showed the patients
treated with nortriptyline to have an increased likeli-
hood of survival at six years (61% vs. placebo 34%).
Nortriptyline (100 mg/day) showed significant im-
provement in comparison with f1uoxetine (40 mg/day)
and placebo". In a double blind study of f1uoxetine
(20 mg/day) versus placebo, Fruehwald et al. showed
that patients on treatment and placebo experienced
comparable improvement during the first 4 weeks,
by 12 weeks patients on fluoxetine continued to im-
prove, while those on placebo experienced recurrence
of symptoms". Citalopram and nortriptyline double
blind studies failed to show improvement of cognitive
deficits even in the presence of depression improve-
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ment. It is important to recognize and diagnose de-
pression after stroke. This is not only because of the
increased suffering depression causes to patients that
already have much to cope with, but because depres-
sion after stroke is associated with worse prognosis
and there is evidence that pharmacological treatment
substantially improves this outlook'":".
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Sazetak
DEPRESIJA NAKON MOZDANOG UDARA
L Zavoreo, V Basii~Kes, M. Bosnar-Puretiii V Demarin
Depresija koja se javlja nakon mozdanog udara jedna je od cdCih komplikacija istog i ima znacajan utjecaj na oporavak
motonckog i kognitivnog ostecenja. pa tako i na smrtnost od mozdanog udara. Ucestalost depresije koja se razvija nakon
mozdanog udara je promjenjiva uz povecanu pojavnost 3-6 mjeseci nakon mozdanog udara, te izrazitu regresiju nakon
godinu dana za oko 50%. Velike depresivne epizode koje se javljaju nakon mozdanog udara spontano regrediraju nakon
godinu do dvije, u teiim slucajevima depresija moze pnjecr u kronicni oblik koji traje tri i vise godina. Pojavnost manjih
depresivnih epizoda nakon mozdanog udara jako varira te [e njihova prevencija i lijecenje individualno. Rano prepozna-
vanje simptoma depresije koja se javlja nakon mozdanog udara te uvodenje specificne farmakoloske terapije od velikog [e
znacenja za smanjenje komplikacija i smrtnosti od mozdanog udara te za poboljsanje funkcionalnog oporavka.
Kljucne rijeci: Moidani udar - komplikaciJe; Moidani udar - psihologiJa; DepresiJa - etiologija; DepresiJa ~ terapiJa liJeko-
vima; DepresiJa - prevenciJa i kontrola
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